Introduction and use of investigational anticancer agents in Australia

Abstract

Medical Journal of AustraliaVolume 141, Issue 4 p. 237-239 Special Article Introduction and use of investigational anticancer agents in Australia First progress report First published: 01 August 1984 https://doi.org/10.5694/j.1326-5377.1984.tb132761.xCitations: 1 Reprints: The Secretary, Anticancer Subcommittee AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Abstract The Anticancer Subcommittee of the Australian Drug Evaluation Committee was established in 1978 to facilitate the obtaining of data on, and the supply of, investigational anticancer agents for use by Australian oncology units. The present report outlines the way in which the usage of specific drugs has developed. Citing Literature Volume141, Issue4August 1984Pages 237-239 RelatedInformation